Our attraction to sugar has grown to an unhealthy level. The average person in the United States now consumes more than 100 ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Yet, despite more than 20 years of study, the sweet receptor’s precise architecture remained elusive, even as scientists ...

At sufficiently high concentrations, some of the compounds called per- and poly-fluoroalkyl substances self-organize into two ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

In 2022, the FDA announced there was a shortage of the brand-name medications, which allowed compounding pharmacies to make generic semaglutide, the main active ingredient in the weight-loss drugs.

For roughly the last two years, the national shortage of tirzepatide and semaglutide has allowed ... the boundaries of federal and state laws and compound these therapies only for individualized ...

Research peptide providers like Direct Peptides have emerged as trusted sources for compounds like Semaglutide, BPC-157, PT-141, NAD+, and Retatrutide, all clearly labeled for research use only.

In their latest study, published online in the Journal of Controlled Release on February 18, 2025, the researchers delved into the mechanisms that govern how long these compounds remain in the ...